| Pancreatic Cancer |
1 |
0.99 |
| Cancer |
0 |
0.93 |
| Otolaryngology |
0 |
0.75 |
| Genomic Medicine |
0 |
0.73 |
| Nasopharyngeal Cancer |
0 |
0.69 |
| Advanced Cancer |
0 |
0.66 |
| Gastrointestinal Cancer |
0 |
0.66 |
| Lung Cancer |
0 |
0.63 |
| Head and Neck Cancer |
0 |
0.61 |
| Hepatocellular Carcinoma |
0 |
0.6 |
| Palliative Care |
0 |
0.58 |
| Small Cell Lung Cancer |
0 |
0.56 |
| Toxicology |
0 |
0.49 |
| Epidermal Growth Factor Receptor |
0 |
0.3 |
| Biliary Disease |
0 |
0.24 |
| KRAS |
0 |
0.23 |
| Healthcare and Medical Technology |
0 |
0.16 |
| Biliary Obstruction |
0 |
0.15 |
| Biomedical Technology |
0 |
0.14 |
| Surgery |
0 |
0.14 |
| Tumor |
0 |
0.14 |
| Chemotherapy |
0 |
0.09 |
| Food and Drug Administration (FDA) |
0 |
0.09 |
| Thrombocytopenia |
0 |
0.09 |
| Biliary Tract |
0 |
0.07 |
| Bile |
0 |
0.05 |
| BRAF |
0 |
0.05 |
| Cervical Region |
0 |
0.05 |
| Clinical Research |
0 |
0.05 |
| clinical-advances |
0 |
0.05 |
| Esophagus |
0 |
0.05 |
| Hospital |
0 |
0.05 |
| Immunotherapy |
0 |
0.05 |
| Leukopenia |
0 |
0.05 |
| Liver |
0 |
0.05 |
| Lung |
0 |
0.05 |
| Medical Oncology |
0 |
0.05 |
| Monoclonal Antibody |
0 |
0.05 |
| Receptors |
0 |
0.05 |
| Melanoma |
0 |
0.04 |
| Neutropenia |
0 |
0.04 |